AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 294: F890-F899, 2008. First published February 6, 2008; doi:10.1152/ajprenal.00341.2007
0363-6127/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/F890    most recent
00341.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohatgi, R.
Right arrow Articles by Satlin, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohatgi, R.
Right arrow Articles by Satlin, L. M.

Mechanoregulation of intracellular Ca2+ in human autosomal recessive polycystic kidney disease cyst-lining renal epithelial cells

Rajeev Rohatgi,1,2 Lorenzo Battini,1 Paul Kim,2 Sharon Israeli,1 Patricia D. Wilson,1 G. Luca Gusella,1 and Lisa M. Satlin1,2

Departments of 1Medicine and 2Pediatrics, The Mount Sinai School of Medicine, New York, New York

Submitted 22 July 2007 ; accepted in final form 1 February 2008


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Mutations of cilia-expressed proteins are associated with an attenuated shear-induced increase in intracellular Ca2+ concentration ([Ca2+]i) in renal epithelial cell lines derived from murine models of autosomal recessive polycystic kidney disease (ARPKD). We hypothesized that human ARPKD cyst-lining renal epithelial cells also exhibited dysregulated mechanosensation. To test this, conditionally immortalized cell lines derived from human fetal ARPKD cyst-lining (pool and clone 5E) cell lines with low levels of fibrocystin/polyductin expression and age-matched normal collecting tubule [human fetal collecting tubule (HFCT) pool and clone 2C] cell lines were grown in culture, loaded with a Ca2+ indicator dye, and subjected to laminar shear. Clonal cell lines were derived from single cells present in pools of cells from cyst-lining and collecting tubules, microdissected from human kidney. Resting and peak [Ca2+]i were similar between ARPKD 5E and pool, and HFCT 2C and pool; however, the flow-induced peak [Ca2+]i was greater in ARPKD 5E (700 ± 87 nM, n = 21) than in HFCT 2C (315 ± 58 nM, n = 12; P < 0.01) cells. ARPKD 5E cells treated with Gd3+, an inhibitor of nonselective cation channels, inhibited but did not abolish the shear-induced [Ca2+]i transient. Cilia were ~20% shorter in ARPKD than HFCT cells, but no difference in ciliary localization or total cellular expression of polycystin-2, a mechanosenory Gd3+-sensitive cation channel, was detected between ARPKD and HFCT cells. The intracellular Ca2+ stores were similar between cells. In summary, human ARPKD cells exhibit an exaggerated Gd3+-sensitive mechano-induced Ca2+ response compared with controls; whether this represents dysregulated polycystin-2 activity in ARPKD cells remains to be explored.

calcium; ion channel; transport; laminar shear stress

AUTOSOMAL RECESSIVE POLYCYSTIC kidney disease (ARPKD) affects ~1:20,000 live births (5, 12, 50). Mortality during the perinatal period is due primarily to respiratory insufficiency; however, in those patients who survive the neonatal period, ~40% develop chronic kidney disease, with a majority developing hypertension during childhood and adolescence (12). Histopathologically, ARPKD kidneys are characterized by ectatic collecting ducts (CDs), which remain contiguous with the filtering nephron (26, 42). ARPKD is caused by mutations in pkhd-1, which encodes the protein product fibrocystin/polyductin (25, 39).

In contrast to ARPKD, autosomal dominant polycystic kidney disease (ADPKD), the most common genetic renal disorder with an incidence of 1:1,000 (36), is characterized by progressive renal disease with a majority of patients developing end-stage renal disease by the 5th decade of life (42). Pathologically, ADPKD kidneys are distinguished by the presence of multiple noncommunicating discrete saccular cysts, which can arise from any segment of the nephron (42). ADPKD is primarily caused by mutations in pkd-1, but, in a minority of cases, are related to mutations of pkd-2 (21).

The mechanisms underlying cystogenesis in ADPKD and ARPKD are incompletely understood. However, cumulative evidence suggests that the central cilium of renal epithelial cells, which is believed to act as a flow sensor (29), may be functionally abnormal in polycystic kidney disease (PKD). In fact, many of the protein products of genes associated with cystic kidney disease localize, at least partially, to the cilium; these include polycystin-1 and polycystin-2, which are encoded by pkd-1 and pkd-2, respectively, polaris which is encoded by Tg737, and fibrocystin/polyductin (1, 2, 11, 21, 25, 34, 39, 40, 48).

Bending of the central cilium of an Madin-Darby canine kidney cell, a model of a distal nephron epithelial cell, either directly by application of suction via a micropipette or indirectly by laminar fluid flow, generates an increase in the intracellular Ca2+ concentration ([Ca2+]i) (29). Homozygous exonic disruption of pkd-1 (pkd-1del34/del34 mutant) abrogates this shear-induced [Ca2+]i transient (23). Mutations of pkd-1 prevent normal expression of polycystin-1 protein in the cilium and also inhibit ciliary expression polycystin-2, a gadolinium (Gd3+)-sensitive, Ca2+-conducting cation channel, in both murine and human models of ADPKD renal epithelia (23, 24, 47). Polycystin-2 localization to the primary cilium, in association with polycystin-1, is necessary for the flow-mediated [Ca2+]i transient in normal renal epithelia (23). The loss of the shear-induced [Ca2+]i response in murine and human models of ADPKD is not a generalized defect in the stimulus-mediated [Ca2+]i response. In fact, ADPKD cells retain their ability to respond to vasopressin, angiotensin II, and thrombin with an increase in [Ca2+]i (23, 47).

The orpk murine model of human ARPKD is associated with mutations in Tg737, whose gene product is important in ciliogenesis (49). CDs from orpk mice microperfused in their native geometry and in monolayers of renal epithelia isolated from orpk mice grown in culture exhibit an attenuated [Ca2+]i response to increases in apical flow rate (19, 33). The attenuated [Ca2+]i response in these cells has been hypothesized to be related to partial redistribution of polycystin-2 from the cilium to the apical membrane (33). In contradistinction to the above data, monolayers of renal epithelial cells derived from the inv/inv mutant mouse, a model of nephronophthisis, show a normal shear-induced [Ca2+]i response, even though mutant inversin, the protein product of inv, is a cilia-associated protein (27, 28, 32). The balance of these studies in mouse and human models of genetic cystic kidney disease suggests that mutations of many, but not all, cilia-associated genes lead to a specific defect in the normal laminar shear stress (LSS)-induced increase in [Ca2+]i.

To date, the effect of laminar shear on [Ca2+]i in human ARPKD cyst-lining cells has not been examined. We hypothesized that human ARPKD cyst-lining renal epithelial cells exhibit abnormal mechanosensation to LSS. The purpose of this study was to test this hypothesis and begin to identify the cellular and molecular pathways involved in this response to LSS by utilizing human ARPKD and age-matched control renal epithelial cells.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Human Renal Epithelial Cell Immortalization

The National Disease Research Interchange (Philadelphia, PA) procured, in the operating room, normal kidneys intended for transplantation, but rejected for surgical reasons or antigen mismatch; those kidneys that experienced warm ischemia before being flushed with Collins salts solution at 4°C were selected. ARPKD kidneys were procured at the time of surgical removal. Specimens were de-identified and assigned anonymous numbers and were exempted for approval by the Institutional Review Board (IRB) by Mount Sinai School of Medicine (MSSM) and National Institutes of Health. Primary cell cultures of normal collecting tubule from age-matched normal kidney or cyst-lining epithelia from ARPKD kidney were generated by microdissection, followed by attachment to type I collagen and grown in 1% serum-containing, fully defined, segment-specific, growth factor-supplemented Click/RPMI media (41, 44). Conditionally immortalized normal and PKD cell lines were derived from these primary cultures by retroviral transduction of a neomycin-resistance and temperature-sensitive T antigen (U58, permissive temperature 33°C) into monolayers during the exponential phase of growth, followed by selection for 6 wk in Geneticin (30). In addition to production of frozen stocks of transduced pools of tubule-specific segments and cyst-lining cells, dilution cloning was carried out, and individual clones were characterized and selected for suitability for study by extensive functional and marker analysis. After transfer of conditionally immortalized cells to the nonpermissive temperature (37°C), T-antigen was absent, and proliferation ceased by 3 days.

Cell Culture for Experimentation

Temperature-sensitive conditionally immortalized cells of ARPKD renal cysts (pool and clone 5E from 19-wk fetal kidney) and age-matched normal fetal collecting tubule [human fetal collecting tubule (HFCT); pool, clone 2C] were grown on rat tail type I collagen-coated 40-mm glass coverslips for perfusion and 18-mm glass coverslips for immunofluorescence microscopy. Clone cells were derived from their respective pool cells, and pool cells were derived from individually microdissected collecting tubules and cysts from freshly collected human kidney, as described above (31). Of note is that ARPKD pool and clone 5E, and HFCT pool and clone 2C, expressed markers characteristic of differentiated principal cells, including the epithelial Na channel, aquaporin-2, and apical cilia (4, 31).

Monolayers were grown to 80% confluence at 33°C in cell-type-specific supplemented medium containing 1% fetal bovine serum, 5 µg/ml human transferrin, and 10–8 M dexamethasone, as previously described (8, 43, 45). Thereafter, they were transferred to 37°C for 8–15 days to maximize differentiation and to elaborate cilia. All cells were placed in serum-free media for 20 min before perfusion or fixation for immunofluorescence microscopy.

Immunofluorescence Microscopy

Cilia length. Cell monolayers grown on 18-mm glass coverslips were fixed and placed in 12-well plastic plates, where they were permeabilized with 0.1% Triton X-100, washed with phosphate-buffered saline (PBS), and blocked with 2% bovine serum albumin (BSA) and 10% normal goat serum in PBS. Cells were incubated with a 1:500 dilution of mouse monoclonal antibody directed against acetylated {alpha}-tubulin (Abcam, Cambridge, MA) overnight at 4°C. After three washes with PBS, a 1:400 dilution of a FITC-conjugated secondary goat anti-mouse IgG (Molecular Probes, Eugene, OR), prepared in a 2% BSA/PBS solution, was applied for 60 min; thereafter, the cells were washed three times with PBS. Before fixation, cilia were flattened for optimal imaging of cilia length. Cell monolayers grown on glass coverslips were placed on a plastic tray at a 45° angle and washed with PBS and fixed with 2.5% paraformaldehyde. Labeled cells on glass coverslips were placed face down on a slide to which 5 µl of Prolong Anti-Fade solution (Molecular Probes) had been applied. Each monolayer was examined by confocal laser scanning microscopy [Leica TCS-SP (UV) microscope; Heidelberg, Germany], and cilia length was calculated with Volocity (Improvision, Lexington, MA).

Localization of polycystin-2. Cells were fixed in 100% methanol at –20°C for 40 min; blocked with 10% normal goat serum, 1% BSA, and 0.05% Triton X-100 in PBS for 1 h; incubated with mouse anti-acetylated {alpha}-tubulin antibody (1:500) and a polyclonal rabbit anti-polycystin-2 antibody (1:500; YCC-2; gift of Dr. S. Somlo) (9) overnight at 4°C; rinsed thrice with PBS; and then incubated for 2 h at room temperature with goat anti-mouse Alexa 568 and goat anti-rabbit Alexa 488 antibodies (Molecular Probes), respectively. Prolong anti-fade agent with 4,6-diamidino-2-phenylindole (DAPI) (Molecular Probes) was applied to each monolayer. Immunofluorescence confocal imaging was performed as described above.

Immunoblotting for Polycystin-2 Expression

HFCT (pool and clone 2C) and ARPKD (pool and clone 5E) cells were grown to confluence in T25 flasks, differentiated at 37°C for 9–13 days, washed with Tris-buffered saline (TBS) containing a comprehensive protease inhibitor cocktail, and then extracted in 1% Nonidet P-40 and 0.5% Triton X-100 solution (8, 31). For polycystin-2 detection, protein lysate (50 µg) from each sample was resolved on a SDS-polyacrylamide gel and electrophoretically blotted onto Immobilon-P membrane (Millipore, Bedford, MA). The membrane was incubated overnight at 4°C with a primary anti-polycystin-2 antibody [H280, Santa Cruz Biotechnology, Santa Cruz, CA; YCC-2(6)], diluted 1:1,000 in 5% milk in PBS containing Tween. Polycystin-2 was detected with peroxidase-conjugated goat anti-rabbit IgG antibody (1:5,000 dilution in 5% milk in PBS containing Tween at room temperature for 30 min) for the H280 antibody or for the YCC-2 antibody. Immunoblots were visualized with an enhanced chemiluminescence (ECL) detection kit, Lumi-Light Plus (Roche Diagnostic, Indianapolis, IN). After stripping the membrane, horseradish peroxidase-conjugated goat anti-actin antibodies (anti-actin C11, Santa Cruz Biotechnology) were used to detect actin and normalize the amount of protein loaded in each lane.

Immunoblotting for Fibrocystin/Polyductin Expression

Protein lysates of HFCT (clone 7F)1 and ARPKD (clone 5E) cells were generated as described above. Fifty micrograms of protein lysate from each sample were loaded onto a 5% SDS-polyacrylamide gel and electrophoretically blotted onto an Immobilon-P membrane (Millipore). The membrane was incubated for 48 h at 4°C with a primary monoclonal mouse anti-fibrocystin antibody (a generous gift from Dr. C. Ward, Mayo Clinic), diluted 1:200 in 5% milk in TBS containing 0.1% Tween (TBST). After washing with TBST, the membrane was incubated for 45 min with an anti-mouse secondary antibody (Invitrogen, Carlsbad, CA) directed against IgG, diluted to 1:10,000 in 5% milk in TBST at room temperature, followed by a 1-h wash and visualization by ECL.

Fifty micrograms of protein from the same protein lysate described above were concurrently electrophoresed on a 10% SDS-polyacrylamide gel and transferred to an Immobilon-P membrane. The membrane was incubated for 48 h with a mouse anti-actin antibody (clone C4 MAB1501; Chemicon) diluted to 1:20,000 in 5% milk in TBST. Thereafter, the membrane was washed, and the blot visualized using an anti-murine secondary antibody (Invitrogen) and ECL.

Real-Time Quantitative PCR

HFCT (clone 7F) and ARPKD (clone 5E) cells were grown to confluence in T25 flasks, differentiated at 37°C for 9–13 days, and collected in RNAlater (Qiagen, Valencia, CA) for RNA isolation and subsequent cDNA synthesis (One Shot, BD Biosciences, Palo Alto, CA). Quantitative real-time PCR was carried out in the Quantitative PCR Shared Resource Facility of the MSSM using specific primers for pkhd-1 and β-actin: pkhd-1 forward 5'GGCTGCAGGCTGAGCTCTAA-3' and pkhd-1 reverse 5'-TGTGACTCAAGGGAGAAATGATCC-3'; β-actin forward 5'-CCCACACTGTGCCCATCTACG-3' and β-actin reverse 5'-GCTTCTCCTTAATGTCACGC-3'. The pkhd-1 and β-actin levels were measured in three replicates of 1 x 106 HFCT and ARPKD cells. To measure the PCR-generated transcripts, SYBRgreen, which fluorescently binds double-stranded DNA, was utilized. Fold changes in pkhd-1 mRNA were determined and normalized to β-actin levels.

Effect of Apical Shear on [Ca2+]i

Cells grown on 40-mm glass coverslips were incubated in serum-free DMEM/F12 media containing 25 µM of fura 2-AM (Molecular Probes), a cell-permeant Ca2+ indicator dye, for 20 min. The cells were placed in a parallel plate-type laminar perfusion chamber (FCS2, Bioptechs, Butler, PA) and set on the stage of a Nikon Eclipse TE300 inverted epifluorescence microscope linked to a cooled Pentamax charge-coupled device camera (Princeton Instruments) interfaced with a digital imaging system (MetaFluor, Universal Imaging, Westchester, PA). The chamber temperature was maintained at 37°C with an FCS2 Temperature Controller (Bioptechs) and perfused using a FCS Micro-Perfusion Pump (Bioptechs). Inhibitors, including 2-aminoethoxydiphenyl borate (2-APB; 10 µM) and Gd3+ (30 µM), were added to the cell superfusate before and throughout the experiment, as indicated. The shear generated across the monolayer was calculated using Poiseulle's law: {tau} = µ{gamma} = 6µQ/a2b, where {tau} is wall stress (dyn/cm2), {gamma} is shear rate (per second), µ is apparent viscosity of the fluid (for buffer media at 37°C = 0.76 cP), a is channel height (cm; 0.025 cm), b is channel width (cm; 1.4 cm), and Q is volumetric rate (ml/s).

Cells in the laminar flow chamber were maintained in serum- and phenol-free DMEM/F12 under a low shear of 0.02–0.05 dyn/cm2 to confirm that baseline [Ca2+]i was stable for 10 min. The pump rate was then abruptly increased to produce a shear of 0.4 dyn/cm2 for 10 min.

The shear of 0.4 dyn/cm2 was selected based on the results of a study aimed at mathematical modeling of the LSS experienced by rabbit CDs and preliminary studies in our own cell lines. In the former study, Liu et al. (20) reported that renal epithelial cells in CDs microperfused at a slow physiological flow rate in their native cylindrical geometry would experience a cilium tip shear of 0.45 dyn/cm2 and a wall shear of 0.52 dyn/cm2. Preliminary experiments in HFCT and ARPKD cells demonstrated that a fluid shear of 0.4 dyn/cm2 produced an increase in [Ca2+]i.

Throughout the experiment, cells were alternately excited at 340 and 380 nm, and images, acquired every 1–15 s, were digitized for subsequent analysis. At the conclusion of each experiment, an intracellular Ca2+ calibration was performed using standard techniques (19). Standard equations were used to calculate experimental values of [Ca2+]i for the cells monitored. Three to nine centrally located cells were analyzed in each monolayer per experiment. The mean baseline [Ca2+]i value for each cell was calculated by averaging the eight [Ca2+]i values measured just before increasing shear. The peak [Ca2+]i was taken as the average of the three highest [Ca2+]i values after induction of LSS.

Measurement of [Ca2+]i Stores

To measure [Ca2+]i stores, baseline [Ca2+]i was measured in ARPKD and HFCT cells loaded with fura 2-AM, under static conditions, before rapidly replacing (within 5 s) the Ca2+-containing perfusate with a nominally Ca2+-free perfusate containing 10 µM ionomycin (13). [Ca2+]i response was measured, and baseline and peak [Ca2+]i were calculated. In addition, the area under the curve was measured utilizing a standard macro in Excel (Microsoft, Redmond, WA), starting at the time that the Ca2+-free perfusate containing ionomycin was added and ending when [Ca2+]i returned to baseline.

Statistics

Data are given as means ± SE (n = number of monolayers). Statistical analyses were performed using paired or unpaired t-tests, as appropriate, and/or ANOVA with multiple-range test and Bonferroni inequality (SigmaStat version 2.03; SPSS, San Rafael, CA). To measure the time required for [Ca2+]i to return to baseline, a paired t-test was utilized to compare the [Ca2+]i values detected at discrete 1-min intervals following shear induction to "time zero," the single [Ca2+]i just before initiating LSS. A value of P ≤ 0.05 was used to assert statistical significance.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Polyductin/Fibrocystin Expression in Human Cell Culture Model

In prior studies, we identified and characterized several biochemically identical clonal cell lines of HFCT renal epithelia of confirmed principal cell origin, as well as ARPKD clonal cells (4, 8, 31, 41, 45). We now sought to confirm that ARPKD cells exhibited altered expression of polyductin/fibrocystin mRNA and protein compared with age-matched controls. Western blot analysis of total cellular protein lysate of HFCT and ARPKD clone cells, immunoblotted utilizing an anti-fibrocystin monoclonal antibody (gift of Dr. Christopher Ward), identified a ~460-kDa band in HFCT cells that was much reduced in ARPKD cells (Fig. 1A). We acknowledge that our human ARPKD cells may express mutant fibrocystin/polyductin protein not identified by our antibodies. Using pkhd-1 primer-specific pairs, we carried out real-time quantitative PCR on total RNA from HFCT and ARPKD clone cells and, similarly, identified reduced pkhd-1 expression in ARPKD cells compared with HFCT cells (Fig. 1B).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		Fig. 1. Western blot and quantitative RT-PCR analysis of fibroycystin/polyductin protein and mRNA expression in human fetal collecting tubule (HFCT) and autosomal recessive polycystic kidney disease (ARPKD) clone cells. A: protein lysates from HFCT and ARPKD clone cells were generated, resolved on a SDS-polyacrylamide gel, electrophoretically blotted onto Immobilon-P membrane, and incubated with an anti-fibrocystin/polyductin antibody. A protein of ~460-kDa molecular weight was detected in HFCT cells, while a faint band at the same molecular weight was detected in ARPKD cells. B: quantitative RT-PCR of total RNA from HFCT and ARPKD clone cells demonstrates a greater abundance of pkhd-1 mRNA expression in HFCT cells than in ARPKD cells.

 
Effect of LSS on [Ca2+]i in HFCT and ARPKD Cells

Murine and human models of ADPKD, as well as the genetically nonorthologous orpk model of ARPKD, exhibited blunted flow-induced increases in [Ca2+]i in cyst-lining cells (19, 23, 24, 33, 47). To test whether human ARPKD cells were similarly limited in their ability to transduce mechanical forces into changes in [Ca2+]i, we studied the effect of LSS on [Ca2+]i in human fetal ARPKD cyst lining renal epithelial cells and age-matched HFCT control cells.

Baseline [Ca2+]i values were first determined under low shear conditions (0.02–0.05 dyn/cm2). The baseline [Ca2+]i in HFCT clone 2C (90 ± 13 nM; n = 12) was similar to that in HFCT pool cells [86 ± 16 nM; n = 7; P = nonsignificant (NS); Fig. 2A], as was baseline [Ca2+]i in ARPKD clone 5E (114 ± 9 nM; n = 21) and ARPKD pool cells (100 ± 12 nM; n = 14; P = NS; Fig. 2B). Baseline [Ca2+]i did not differ between ARPKD and HFCT cells (P = NS).


Figure 2
View larger version (20K):
[in this window]
[in a new window]

  		Fig. 2. Laminar shear stress-induced changes in intracellular Ca2+ concentration ([Ca2+]i) in HFCT and ARPKD cells. A: baseline [Ca2+]i is similar in HFCT 2C and pool cells, as is the peak [Ca2+]i after flow is initiated. Both clone and pool cells respond to flow with a significant increase in [Ca2+]i (*P < 0.05 vs. low shear). B: ARPKD 5E and pool cells have similar baseline and peak [Ca2+]i. ARPKD clone and pool cells respond to flow with a significant increase in peak [Ca2+]i (*P < 0.05 vs. low shear). The shear-induced peak [Ca2+]i is greater in ARPKD 5E than HFCT 2C (#P < 0.05 vs. HFCT clone). C: HFCT 2C (solid circles) and pool (shaded circles) cells exhibit similar [Ca2+]i transients as do ARPKD 5E (shaded circles) and pool (solid circles) cells (D) in response to shear. However, the peak [Ca2+]i induced by flow is greater in ARPKD than HFCT cells (A and B).

 
An abrupt increase in apical LSS to 0.4 dyn/cm2 resulted in similar and significant (P < 0.05 compared with values at low shear) increases in peak [Ca2+]i in HFCT clone 2C (to 315 ± 58 nM; n = 12) and HFCT pool cells (321 ± 83 nM; n = 7; Fig. 2A). An identical increase in LSS also induced a significant increase in [Ca2+]i in ARPKD clone 5E (to 700 ± 87 nM; n = 21) and ARPKD pool cells (612 ± 125 nM; n = 14) to a value significantly exceeding baseline [Ca2+]i (Fig. 2B; P < 0.05 compared with values at low shear). The LSS-induced peak [Ca2+]i in ARPKD clone 5E was greater than peak LSS-induced peak [Ca2+]i detected in HFCT clone 2C (Fig. 2, A and B; P < 0.05).

The time course of the [Ca2+]i response to shear was similar in HFCT clone 2C and HFCT pool cells (Fig. 2C), and ARPKD clone 5E and HFCT pool cells (Fig. 2D). Following an increase in flow, the [Ca2+]i in ARPKD cells returned to baseline by 10 min, whereas HFCT cells had reached baseline [Ca2+]i after 6 min. Because the baseline [Ca2+]i, LSS-induced peak [Ca2+]i, and the time course of the LSS-induced [Ca2+]i transient were identical in clone and pool cells, we concluded that the clone cells represent a valid model of the pool cells isolated from the individually microdissected collecting tubules and cysts from which they were derived. Thus, in contradistinction to other models of ARPKD and ADPKD, human ARPKD renal epithelial cells exhibit an exaggerated [Ca2+]i response to LSS compared with controls.

Source of Ca2+ Giving Rise to LSS-Induced [Ca2+]i Response

We next sought to determine whether the observed difference in LSS-induced peak [Ca2+]i between ARPKD and HFCT cells was due to a difference in extracellular Ca2+ entry or internal Ca2+ store release. To evaluate this, ARPKD clone 5E cells were treated with specific inhibitors of extracellular Ca2+ entry and/or intracellular Ca2+ release for 30 min before and throughout the duration of the experiment.

Pretreatment of ARPKD 5E cells with Gd3+ (30 µM), an inhibitor of nonselective cation channels, including polycystin-2, did not affect baseline [Ca2+]i (Fig. 3), but significantly reduced the peak [Ca2+]i elicited by LSS (336 ± 58 nM; n = 6; P < 0.05 vs. control ARPKD clone 5E; Fig. 3), consistent with the notion that extracellular Ca2+ entry contributes to the mechano-induced response. The baseline and peak [Ca2+]i elicited by shear in these Gd3+-treated ARPKD cells was not different from that observed in untreated HFCT 2C cells (Fig. 2A, P = NS). [Ca2+]i in Gd3+-treated ARPKD cells returned to baseline within 6 min, as did untreated HFCT clone 2C cells (Fig. 4). Gd3+ treatment did not affect the LSS-induced peak [Ca2+]i response in HFCT clone 2C cells (275 ± 32 nM; n = 5, P = NS compared with control HFCT 2C; data not shown). In summary, these data suggest that the exaggerated shear-induced increase in [Ca2+]i in ARPKD 5E compared with HFCT 2C cells is due to extracellular Ca2+ entry through Gd3+-sensitive mechano-sensitive cation channels.


Figure 3
View larger version (20K):
[in this window]
[in a new window]

  		Fig. 3. Mechanisms underlying the shear-induced [Ca2+]i response in ARPKD cells. ARPKD 5E cells studied in Ca2+-free medium, or in the presence of 30 µM Gd3+ or 10 µM 2-aminoethoxydiphenyl borate (2-APB), retained their ability to respond to shear with an increase in [Ca2+]i (*P < 0.05 vs. [Ca2+]i values under low shear). However, all treatments blunted the peak [Ca2+]i elicited by flow compared with the untreated ARPKD control (#P < 0.05 vs. untreated ARPKD cells). The baseline [Ca2+]i was lower ($P < 0.05 vs. control) in ARPKD cells studied in Ca2+-free media than in control cells.

 

Figure 4
View larger version (17K):
[in this window]
[in a new window]

  		Fig. 4. Shear-mediated [Ca2+]i transient in HFCT 2C control and ARPKD 5E cells treated with Gd3+. ARPKD 5E cells (shaded circles) treated with Gd3+ exhibited a similar shear-induced [Ca2+]i response to HFCT 2C controls (solid circles). In ARPKD 5E cells treated with Gd3+, [Ca2+]i fell to a value that was identical to that measured at baseline at 6 min, as did HFCT 2C cells.

 
Removal of Ca2+ from the perfusate (Ca2+ free) resulted in a reduction in baseline [Ca2+]i (44 ± 7 nM; n = 3; P < 0.05 vs. control) (Fig. 3) (10). LSS induced a small, yet significant, increase in peak [Ca2+]i (82 ± 10 nM; n = 3; P < 0.05 vs. baseline [Ca2+]i) (Fig. 3) in ARPKD 5E cells studied in the nominal absence of extracellular Ca2+, presumably reflecting internal Ca2+ store release, although the peak [Ca2+]i elicited was less than observed in the presence of extracellular Ca2+ (P < 0.05 vs. control) (Fig. 3). Treatment of ARPKD 5E cells with 10 µM 2-APB, an inhibitor of the inositol 1,4,5-triphosphate receptor (IP3R) (23) and capacitative Ca2+ entry (14), did not alter baseline [Ca2+]i, but led to a significant reduction in peak [Ca2+]i (179 ± 3 nM; n = 6; P < 0.05 vs. control) (Fig. 3) elicited by LSS and a return to baseline [Ca2+]i by 3 min in the continued presence of LSS (data not shown). In summary, these data suggest that the [Ca2+]i response induced by LSS in ARPKD cyst lining cells is mediated by internal Ca2+ store release, as well as Gd3+-sensitive extracellular Ca2+ entry.

Internal Ca2+ Stores in ARPKD and HFCT Cells

Polycystin-2 is expressed not only in the cilium, but also in the endoplasmic reticulum (ER), where it can interact with IP3R and/or ryanodine receptors to release Ca2+ from the ER (3, 16, 18). Dysregulated function of polycystin-2 within the ER may alter internal Ca2+ stores, which, in turn, may contribute to differences in LSS-mediated [Ca2+]i responses observed between ARPKD and HFCT cells. We utilized ionomycin, a Ca2+ ionophore, in nominally Ca2+-free perfusate to mobilize cellular Ca2+ stores in ARPKD and HFCT cells. The peak [Ca2+]i elicited by ionomycin in ARPKD (658 ± 209 nM; n = 9) and HFCT (876 ± 258 nM; n = 6; P = NS) cells was similar. Because peak [Ca2+]i may not reflect the total Ca2+ in intracellular stores, we measured the area under the curve, as described in MATERIALS AND METHODS, and also found no difference between ARPKD (62.0 ± 25.3 µM * s; n = 9) and HFCT (105.4 ± 32.4 µM * s; n = 6; P = NS).

Localization of Polycystin-2 in HFCT Clone 2C and ARPKD Clone 5E

The results above suggest that extracellular Ca2+ entry induced by LSS is mediated by a Gd3+-sensitive mechanosensory Ca2+ channel. One such candidate channel is polycystin-2, a protein that is normally expressed in human fetal kidney, mutations or mislocalization of which are associated with cystic kidney disease, and a channel protein that is to some extent regulated by fibrocystin/polyductin (7, 33, 37, 38, 46). To determine whether aberrant localization of polycystin-2 contributes to the difference in the shear-mediated [Ca2+]i response between HFCT and ARPKD cells, monolayers of HFCT clone 2C and ARPKD clone 5E (Fig. 5) were labeled with anti-polycystin-2 antibody (YCC-2), anti-acetylated {alpha}-tubulin antibody, and DAPI to identify cilia and nuclei, respectively. Of note was that cilia length tended to be shorter in ARPKD clone 5E (6.5 ± 0.6 µm; n = 15) compared with HFCT clone 2C (8.5 ± 0.8 µm; n = 21; P = 0.05) cells. In HFCT clone 2C, polycystin-2 localized to cilia, identified by anti-acetylated {alpha}-tubulin antibody staining (Fig. 5, A–D; arrow in 5D indicates colocalization). Polycystin-2 expression was also prominently detected in cilia of ARPKD clone 5E cells (Fig. 5, E–H; arrows). Immunolocalization studies using the commercially available rabbit anti-polycystin-2 antibody (H280, Santa Cruz Biotechnology) also demonstrated identical polycystin-2 expression in cilia of ARPKD and HFCT cells (data not shown).


Figure 5
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 5. Localization of polycystin-2 in HFCT and ARPKD cells. Enface image of HFCT cells labeled with anti-acetylated {alpha}-tubulin antibody for cilia (red; A) and 4,6-diamidino-2-phenylindole (DAPI) for nuclei (blue; C) demonstrates that polycystin-2 (green; B) is detected in the cilia (merged; D). Similar labeling of ARPKD cells with anti-acetylated {alpha}-tubulin antibody for cilia (red; E) and DAPI for nuclei (blue; G) demonstrates that polycystin-2 (green; F) is found prominently in cilia (merged; H) of human ARPKD renal epithelial cells.

 
Polycystin-2 Expression in HFCT and ARPKD Cells

Immunoblotting of protein lysates prepared from HFCT pool and ARPKD pool cells with anti-polycystin-2 antibody H280 (Fig. 6A) or YCC-2 (Fig. 6B) identified a ~110-kDa band in all samples, which is believed to be endogenous polycystin-2 protein. Densitometric analysis of the bands identified by the H280 antibody compared with actin, and then normalized to the values obtained in HFCT cells, showed that ARPKD cells (n = 3) expressed ~40% more polycystin-2 than did HFCT cells (n = 3), but this difference was not statistically significant (Fig. 6A; P = 0.5). Similarly, densitometric analysis of the immunoblot probed with the well-characterized YCC-2 antibody (6) demonstrated a tendency for polycystin-2 expression to be greater in ARPKD than in HFCT cells (Fig. 6B; P = 0.07). Because of the greater difference in expression between ARPKD and HFCT cells observed with the YCC-2 antibody, the polycystin-2 bands in the HFCT cells were barely visible using exposure times that avoided saturation of the ARPKD signal (Fig. 6B).


Figure 6
View larger version (17K):
[in this window]
[in a new window]

  		Fig. 6. Immunoblotting for polycystin-2 expression. Protein lysate (50 µg/lane) derived from ARPKD and HFCT pool cells was immunoblotted with anti-polycystin-2 antibody H280 (A) or YCC-2 (B). A 110-kDa protein was detected both in ARPKD and HFCT lysates probed with either anti-polycystin-2 antibody. A: densitometric analysis of the 110-kDa protein normalized to actin and then to the values obtained in HFCT cells, showed an insignificant increase in polycystin-2 abundance in ARPKD cells (n = 3) compared with HFCT cells (n = 3, P = 0.5). B: densitometry of immunoblots incubated with YCC-2 showed that polycystin-2 expression in ARPKD cells (n = 3) tended to be greater than in HFCT cells (n = 3, P = 0.07).

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The results of this present study are, to our knowledge, the first to examine mechanoregulation of renal epithelial function in human ARPKD cyst-lining cells, and reveal two novel findings. First, ARPKD cells exhibit an exaggerated LSS-induced increase in [Ca2+]i compared with age-matched control HFCT cells (Fig. 2). All other reported analyses of the effect of flow on [Ca2+]i in murine models of ARPKD and ADPKD and human models of ADPKD reveal that these cystic cell types exhibit a blunted LSS-induced [Ca2+]i response (23, 24, 33, 47). Note that baseline [Ca2+]i under low-shear conditions was similar in human ARPKD and HFCT cells, as has been reported in the murine orpk model of ARPKD (19). Our observation that pretreatment of ARPKD clone 5E with Gd3+ "normalized" the magnitude of the shear-induced peak [Ca2+]i transient and accelerated the fall to baseline to generate a [Ca2+]i response that was indistinguishable from HFCT controls suggests that the fetal ARPKD cells express an upregulated mechanosensitive cation entry pathway. Our second major finding is that polycystin-2, a mechano- and Gd3+-sensitive Ca2+ channel absent from cilia of human ADPKD renal epithelial cells (24, 47), localized to the cilium of human ARPKD cells, tended to be more highly expressed in the latter cells compared with age-matched controls. The precise relationship of the robust ciliary polycystin-2 expression in human ARPKD cells to the exaggerated shear-induced Gd3+-sensitive [Ca2+]i transient remains to be clarified, as is the relationship of this pathway to that mediating enhanced transepithelial Na absorption in human ARPKD compared with HFCT that our laboratory has previously described (31).

Similar studies to those included in this investigation have been performed utilizing renal epithelia from the orpk murine model of ARPKD, which is genetically distinct from human ARPKD, but develops cystic renal disease that is phenotypically similar to ARPKD. In a series of elegant studies performed by Siroky et al. (33) in orpk mice, immunodetectable polycystin-2 was expressed not only in the stunted cilium, but also prominently along the apical membrane (33). Patch-clamp and Mn2+ quenching experiments demonstrated that apically localized polycystin-2 channel was functional in orpk renal epithelial cells (33). These results suggested that apical polycystin-2 channel activity and/or number was greater in orpk than in control cells (33). Using an open-flow chamber design, as opposed to the closed chamber utilized in our experiments, the authors of the latter study detected a markedly attenuated shear-induced [Ca2+]i response in orpk mutant compared with control cells (33). Murine embryonic renal epithelial cells and murine inner medullary CD cells, in which endogenous fibrocystin/polyductin mRNA and protein were knocked down, also demonstrated an attenuated LSS-induced [Ca2+]i transient compared with controls (38); however, the knockdown studies were not able to abrogate the LSS-mediated [Ca2+]i response.

Our findings in a human ARPKD model contradict those of Siroky et al. (33) and Wang et al. (38) in that we observed an augmented [Ca2+]i response to shear in ARPKD compared with control renal epithelial cells. The augmented shear-induced [Ca2+]i response in our study may be related to the species studied (mouse vs. human), developmental stage (postnatal vs. fetal), or genetic differences between the murine orpk (tg737) and human ARPKD (pkhd-1) models. Although the renal disease is phenotypically similar, the orpk mouse also develops preaxial polydactyly and hydrocephalus not observed in human ARPKD (22, 35). Also, the expression of mutant protein in human cells may reflect some of the disparate results seen between our human model and the fibrocystin/polyductin knockdown model used by Wang et al. (38).

The exaggerated shear-induced [Ca2+]i response in human ARPKD cells is due, in part, to extracellular Ca2+ entry via mechano- and Gd3+-sensitive cation channels. Our observation, that pretreatment of cells with Gd3+ or removal of extracellular Ca2+ did not completely abolish the shear-induced [Ca2+]i response in ARPKD cells (Fig. 3) and that 2-APB reduced the shear-mediated peak [Ca2+]i to a value below that observed in HFCT cells, suggests that both IP3R and/or store-operated Ca2+ channels contribute to the [Ca2+]i response (Fig. 3). As others have suggested, shear initiates extracellular Ca2+ entry through mechano- and Gd3+-sensitive Ca2+ channels, and the increase in [Ca2+]i triggers Ca2+-activated Ca2+ release from internal stores (20, 23, 29). Internal store release then activates store-operated Ca2+ channels at the membrane (17). We speculate that the prolonged elevation in LSS-induced [Ca2+]i in ARPKD cells may be related to activation of store-operated Ca2+ channels.

Although polycystin-2 is expressed in the cilium (9) (Fig. 5), the bulk of endogenous polycystin-2 is localized to the ER membrane, where it is proposed to function as an intracellular Ca2+ release channel (15). LLC-PK cells overexpressing polycystin-2 in the ER and bathed in Ca2+-free media respond to IP3R activation with a twofold greater peak [Ca2+]i response of 10-fold greater duration compared with vehicle-transfected cells (15). Li et al. (18), using polycystin-2 transfected Xenopus oocytes, showed that polycystin-2 and IP3R directly interact, and that polycystin-2 prolongs the duration of the IP3R-activated Ca2+ transient. The observation that overexpression of polycystin-2 in the ER can prolong the amplitude and/or duration of the IP3R-mediated Ca2+ transient is particularly intriguing, given the nature of our results.

Fibrocystin/polyductin, the mutant protein in ARPKD, interacts with polycystin-2 (46). Wu et al. (46) and Wang et al. (38) demonstrated that fibrocystin activates polycystin-2 channel activity through a mediator protein, kif3b, that is a component of the kinesin-2 complex. Fibrocystin-kif3b-polycystin-2 forms a heterotrimeric complex by which fibrocystin modulates polycystin-2 channel activity in the cilium. Although we were unable to identify any significant differences in polycystin-2 expression between ARPKD cyst lining cells and age-matched control cells, we speculate that the exaggerated Ca2+ response in the former reflects dysregulated channel expression and activity, due to aberrant interactions with mutant fibrocystin.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants PO1 DK62345 (P. D. Wilson, L. M. Satlin), RO1 DK038470 and RO1 DK051391 (L. M. Satlin), and KO8 DK062172 (R. Rohatgi). Confocal laser scanning microscopy was performed at the Mount Sinai School of Medicine-Microscopy Shared Resource Facility, supported with funding from National Institutes of Health (NIH)-National Cancer Institute Shared Resources Grant (5R24 CA095823-04), National Science Foundation Major Research Instrumentation Grant (DBI-9724504), and NIH Shared Instrumentation Grant (1S10RR09145-01).


   ACKNOWLEDGMENTS
 
The authors gratefully acknowledge the technical assistance of B. Zavilowitz and the University of Alabama at Birmingham Recessive Polycystic Kidney Disease Core Center (5P30DK07038), the insightful discussions with Dr. L. Guay-Woodford, the generous gift of the anti-polycystin-2 antibody from Dr. S. Somlo, and the generous gift of the anti-fibrocystin/polyductin antibody from Dr. C. Ward.

An abstract of this work was presented at the FASEB summer research conference on polycystic kidney disease at Saxtons River, VT, August 2005, and the Annual Meeting of the American Society of Nephrology in San Diego, CA, November 2006.


   FOOTNOTES
 

Address for reprint requests and other correspondence: R. Rohatgi, The Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1243, New York, New York 10029 (e-mail: Rajeev.Rohatgi{at}mssm.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 HFCT clone 7F was used for the immunoblot and real-time PCR of fibrocystin/polyductin. HFCT clones 7F and 2C have been shown to be interchangeable in their biochemical characteristics (4, 8, 41, 45). Back


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. [Anon]. The polycystic kidney disease 1 gene encodes a 14 kb transcript, and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 77: 881–894, 1994.[CrossRef][Web of Science][Medline]
  2. [Anon]. Polycystic kidney disease: the complete structure of the P.KD1 gene, and its protein. The International Polycystic Kidney Disease Consortium. Cell 81: 289–298, 1995.[CrossRef][Web of Science][Medline]
  3. Anyatonwu GI, Estrada M, Tian X, Somlo S, Ehrlich BE. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc Natl Acad Sci USA 104: 6454–6459, 2007.[Abstract/Free Full Text]
  4. Aviles D, Burrow CR, Wilson PD, Manning J, Carmichael MC, Vehaskari VM. Characterization of a human fetal cell line resembling collecting duct principal cell (Abstract). J Am Soc Nephrol 8: 357A, 1997.
  5. Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schoneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Buttner R, Zerres K. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int 67: 829–848, 2005.[CrossRef][Web of Science][Medline]
  6. Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, Mochizuki T, Park JH, Witzgall R, Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 274: 28557–28565, 1999.[Abstract/Free Full Text]
  7. Chauvet V, Qian F, Boute N, Cai Y, Phakdeekitacharoen B, Onuchic LF, Attie-Bitach T, Guicharnaud L, Devuyst O, Germino GG, Gubler MC. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. Am J Pathol 160: 973–983, 2002.[Abstract/Free Full Text]
  8. Geng L, Burrow CR, Li HP, Wilson PD. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta 1535: 21–35, 2000.[Medline]
  9. Geng L, Okuhara D, Yu Z, Tian X, Cai Y, Shibazaki S, Somlo S. Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif. J Cell Sci 119: 1383–1395, 2006.[Abstract/Free Full Text]
  10. Gordjani N, Nitschke R, Greger R, Leipziger J. Capacitative Ca2+ entry (CCE) induced by luminal and basolateral ATP in polarised MDCK-C7 cells is restricted to the basolateral membrane. Cell Calcium 22: 121–128, 1997.[CrossRef][Web of Science][Medline]
  11. Guay-Woodford LM. Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex. Pediatr Nephrol 21: 1369–1376, 2006.[CrossRef][Web of Science][Medline]
  12. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111: 1072–1080, 2003.[Abstract/Free Full Text]
  13. Hooper KM, Boletta A, Germino GG, Hu Q, Ziegelstein RC, Sutters M. Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells. Am J Physiol Renal Physiol 289: F521–F530, 2005.[Abstract/Free Full Text]
  14. Iwasaki H, Mori Y, Hara Y, Uchida K, Zhou H, Mikoshiba K. 2-Aminoethoxydiphenyl borate (2-APB) inhibits capacitative calcium entry independently of the function of inositol 1,4,5-trisphosphate receptors. Receptors Channels 7: 429–439, 2001.[Web of Science][Medline]
  15. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4: 191–197, 2002.[CrossRef][Web of Science][Medline]
  16. Koulen P, Duncan RS, Liu J, Cohen NE, Yannazzo JA, McClung N, Lockhart CL, Branden M, Buechner M. Polycystin-2 accelerates Ca2+ release from intracellular stores in Caenorhabditis elegans. Cell Calcium 37: 593–601, 2005.[CrossRef][Web of Science][Medline]
  17. Lewis RS. The molecular choreography of a store-operated calcium channel. Nature 446: 284–287, 2007.[CrossRef][Medline]
  18. Li Y, Wright JM, Qian F, Germino GG, Guggino WB. Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling. J Biol Chem 280: 41298–41306, 2005.[Abstract/Free Full Text]
  19. Liu W, Murcia NS, Duan Y, Weinbaum S, Yoder BK, Schwiebert E, Satlin LM. Mechanoregulation of intracellular Ca2+ concentration is attenuated in collecting duct of monocilium-impaired orpk mice. Am J Physiol Renal Physiol 289: F978–F988, 2005.[Abstract/Free Full Text]
  20. Liu W, Xu S, Woda C, Kim P, Weinbaum S, Satlin LM. Effect of flow and stretch on the [Ca2+]i response of principal and intercalated cells in cortical collecting duct. Am J Physiol Renal Physiol 285: F998–F1012, 2003.[Abstract/Free Full Text]
  21. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339–1342, 1996.[Abstract]
  22. Moyer JH, Lee-Tischler MJ, Kwon HY, Schrick JJ, Avner ED, Sweeney WE, Godfrey VL, Cacheiro NL, Wilkinson JE, Woychik RP. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264: 1329–1333, 1994.[Abstract/Free Full Text]
  23. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129–137, 2003.[CrossRef][Web of Science][Medline]
  24. Nauli SM, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber DE, Loghman-Adham M, Zhou J. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J Am Soc Nephrol 17: 1015–1025, 2006.[Abstract/Free Full Text]
  25. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schoneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70: 1305–1317, 2002.[CrossRef][Web of Science][Medline]
  26. Osathanondh V, Potter EL. Pathogenesis of cystic kidneys: historical survey; survey of results of microdissection. Arch Pathol 77: 459–473, 1964.[Web of Science][Medline]
  27. Otto EA, Schermer B, Obara T, O'Toole JF, Hiller KS, Mueller AM, Ruf RG, Hoefele J, Beekmann F, Landau D, Foreman JW, Goodship JA, Strachan T, Kispert A, Wolf MT, Gagnadoux MF, Nivet H, Antignac C, Walz G, Drummond IA, Benzing T, Hildebrandt F. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat Genet 34: 413–420, 2003.[CrossRef][Web of Science][Medline]
  28. Phillips CL, Miller KJ, Filson AJ, Nurnberger J, Clendenon JL, Cook GW, Dunn KW, Overbeek PA, Gattone VH 2nd, Bacallao RL. Renal cysts of inv/inv mice resemble early infantile nephronophthisis. J Am Soc Nephrol 15: 1744–1755, 2004.[Abstract/Free Full Text]
  29. Praetorius HA, Spring KR. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 184: 71–79, 2001.[CrossRef][Web of Science][Medline]
  30. Racusen LC, Wilson PD, Hartz PA, Fivush BA, Burrow CR. Renal proximal tubular epithelium from patients with nephropathic cystinosis: immortalized cell lines as in vitro model systems. Kidney Int 48: 536–543, 1995.[Web of Science][Medline]
  31. Rohatgi R, Greenberg A, Burrow CR, Wilson PD, Satlin LM. Na transport in autosomal recessive polycystic kidney disease (ARPKD) cyst lining epithelial cells. J Am Soc Nephrol 14: 827–836, 2003.[Abstract/Free Full Text]
  32. Shiba D, Takamatsu T, Yokoyama T. Primary cilia of inv/inv mouse renal epithelial cells sense physiological fluid flow: bending of primary cilia and Ca2+ influx. Cell Struct Funct 30: 93–100, 2005.[CrossRef][Web of Science][Medline]
  33. Siroky BJ, Ferguson WB, Fuson AL, Xie Y, Fintha A, Komlosi P, Yoder BK, Schwiebert EM, Guay-Woodford LM, Bell PD. Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells. Am J Physiol Renal Physiol 290: F1320–F1328, 2006.[Abstract/Free Full Text]
  34. Smith LA, Bukanov NO, Husson H, Russo RJ, Barry TC, Taylor AL, Beier DR, Ibraghimov-Beskrovnaya O. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. J Am Soc Nephrol 17: 2821–2831, 2006.[Abstract/Free Full Text]
  35. Taulman PD, Haycraft CJ, Balkovetz DF, Yoder BK. Polaris, a protein involved in left-right axis patterning, localizes to basal bodies and cilia. Mol Biol Cell 12: 589–599, 2001.[Abstract/Free Full Text]
  36. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007.[CrossRef][Web of Science][Medline]
  37. Tsiokas L, Kim S, Ong EC. Cell biology of polycystin-2. Cell Signal 19: 444–453, 2007.[CrossRef][Web of Science][Medline]
  38. Wang S, Zhang J, Nauli SM, Li X, Starremans PG, Luo Y, Roberts KA, Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol 27: 3241–3252, 2007.[Abstract/Free Full Text]
  39. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30: 259–269, 2002.[CrossRef][Web of Science][Medline]
  40. Ward CJ, Yuan D, Masyuk TV, Wang X, Punyashthiti R, Whelan S, Bacallao R, Torra R, LaRusso NF, Torres VE, Harris PC. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet 12: 2703–2710, 2003.[Abstract/Free Full Text]
  41. Wilson PD. In vitro methods in renal research. In: Pedatric Nephrology (5th Ed.), edited by Avner ED, Harmon WE, and Naiudet P. Philadelphia, PA: Lippincott Williams & Wilkins, 2004, p. 318–333.
  42. Wilson PD. Polycystic kidney disease. N Engl J Med 350: 151–164, 2004.[Free Full Text]
  43. Wilson PD, Devuyst O, Li X, Gatti L, Falkenstein D, Robinson S, Fambrough D, Burrow CR. Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the beta2 isoform. Am J Pathol 156: 253–268, 2000.[Abstract/Free Full Text]
  44. Wilson PD, Dillingham MA, Breckon R, Anderson RJ. Defined human renal tubular epithelia in culture: growth, characterization, and hormonal response. Am J Physiol Renal Fluid Electrolyte Physiol 248: F436–F443, 1985.[Abstract/Free Full Text]
  45. Wilson PD, Geng L, Li X, Burrow CR. The PKD1 gene product, "polycystin-1", is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab Invest 79: 1311–1323, 1999.[Web of Science][Medline]
  46. Wu Y, Dai XQ, Li Q, Chen CX, Mai W, Hussain Z, Long W, Montalbetti N, Li G, Glynne R, Wang S, Cantiello HF, Wu G, Chen XZ. Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Hum Mol Genet 15: 3280–3292, 2006.[Abstract/Free Full Text]
  47. Xu C, Rossetti S, Jiang L, Harris PC, Brown-Glaberman U, Wandinger-Ness A, Bacallao RL, Alper SL. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am J Physiol Renal Physiol 292: F930–F945, 2007.[Abstract/Free Full Text]
  48. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13: 2508–2516, 2002.[Abstract/Free Full Text]
  49. Yoder BK, Tousson A, Millican L, Wu JH, Bugg CE Jr, Schafer JA, Balkovetz DF. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am J Physiol Renal Physiol 282: F541–F552, 2002.[Abstract/Free Full Text]
  50. Zerres K, Rudnik-Schoneborn S, Steinkamm C, Becker J, Mucher G. Autosomal recessive polycystic kidney disease. J Mol Med 76: 303–309, 1998.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Xu, B. E. Shmukler, K. Nishimura, E. Kaczmarek, S. Rossetti, P. C. Harris, A. Wandinger-Ness, R. L. Bacallao, and S. L. Alper
Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells
Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1464 - F1476.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/F890    most recent
00341.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohatgi, R.
Right arrow Articles by Satlin, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohatgi, R.
Right arrow Articles by Satlin, L. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.